Nanotechnology in Medicine: Revolutionizing Drug Delivery Systems
DOI:
https://doi.org/10.71465/jhmri79Keywords:
Nanotechnology, Drug Delivery Systems, Nanocarriers, Targeted TherapyAbstract
Nanotechnology, the manipulation of matter at the nanoscale, has made significant strides in various fields, including medicine. In drug delivery, nanotechnology has the potential to revolutionize traditional methods, providing controlled release, enhanced bioavailability, and targeted delivery of therapeutic agents. This article discusses the impact of nanotechnology on drug delivery systems, focusing on the advancements in nanocarriers such as liposomes, dendrimers, and nanoparticles. These innovations promise to overcome several limitations of conventional drug delivery, including poor solubility, instability, and nonspecific distribution. The integration of nanotechnology into medicine has the potential to improve the efficacy and safety of drugs, providing more precise treatment options for various diseases, including cancer, diabetes, and neurological disorders.
References
Smith, J., & Lee, H. (2019). Advances in nanotechnology for drug delivery systems. Journal of Pharmaceutical Sciences, 108(7), 123-135.
Khan, F., & Shah, A. (2020). Targeted drug delivery using nanoparticles: A review. Pakistani Journal of Pharmaceutical Sciences, 33(2), 256-270.
Ahmed, M., & Javed, S. (2018). Nanoparticles in cancer therapy: A review of recent developments. Nanomedicine: Nanotechnology, Biology, and Medicine, 14(4), 1077-1090.
Iqbal, Z., & Khan, A. (2021). Drug delivery systems: Challenges and opportunities. Pakistani Journal of Nanotechnology, 2(1), 45-55.
Javed, A., & Kumar, R. (2022). Dendrimers in drug delivery: A comprehensive review. Journal of Controlled Release, 349, 89-101.
Sharma, V., & Bansal, V. (2020). Liposomes in drug delivery: From fundamental concepts to clinical applications. International Journal of Nanomedicine, 15, 7319-7334.
Ali, N., & Iqbal, M. (2020). Applications of liposomes in targeted drug delivery. Journal of Drug Delivery Science and Technology, 55, 101-113.
Ahmad, Z., & Shahid, S. (2021). Nanotechnology for targeted drug delivery in cancer treatment. Advanced Drug Delivery Reviews, 181, 34-45.
Yaqoob, N., & Bukhari, H. (2020). Nanocarriers in drug delivery: Challenges and opportunities. Nanomedicine, 15(2), 105-118.
Raza, S., & Malik, A. (2022). Biocompatibility and toxicity of nanocarriers in drug delivery. Journal of Nanobiotechnology, 20(1), 45-57.
Farooq, M., & Latif, M. (2019). Nanotechnology in personalized medicine: A future perspective. Trends in Nanotechnology, 10(2), 22-30.
Khan, Z., & Naseer, M. (2021). Advanced nanoparticles for drug delivery in cancer therapy. Journal of Cancer Research and Clinical Oncology, 147(3), 551-563.
Ahmad, M., & Ali, S. (2020). Clinical applications of nanotechnology in drug delivery systems. Current Nanoscience, 16(7), 941-957.
Malik, I., & Imran, M. (2020). Challenges in the development of nanomedicines. Biomedical Nanotechnology Journal, 6(2), 120-135.
Jameel, F., & Bibi, S. (2020). The future of nanotechnology in medicine. Scientific Advances in Medicine, 15(4), 67-79.
Aslam, S., & Usman, H. (2021). The role of nanocarriers in brain drug delivery. Frontiers in Neuroscience, 14, 234-245.
Rasheed, M., & Usman, F. (2022). Nanotechnology-based strategies for targeting drug delivery. Journal of Nanoscience and Nanotechnology, 22(4), 1550-1562.
Imran, F., & Naseer, R. (2021). Nanoparticle drug delivery systems for cancer treatment. Nanomedicine: Nanotechnology, Biology, and Medicine, 17, 107-119.
Iqbal, N., & Tariq, S. (2020). Targeted cancer therapy using nanocarriers: Progress and challenges. Pharmaceutics, 12(8), 512-524.
Saeed, S., & Raza, S. (2020). The impact of nanotechnology on healthcare: A review. Current Opinion in Pharmacology, 50, 1-8.
Safdar, M. R. (2023). Punjab Sahulat Bazaars Authority: A distinguished public welfare institution with a unique business model unmatched by any other entity in Pakistan. Contemporary Journal of Social Science Review, 3(3), Article 1311. https://doi.org/10.63878/cjssr.v3i3.1311
Ahmad, N. R. (2025). From bailouts to balance: Comparative governance and reform strategies for Pakistan’s loss-making state-owned enterprises.
Naqvi, S. S., & Rizwan, M. (2021). Decolonised representation of Jihad narrative: Construction of religious misrepresentations (Part II). Kashmir Journal of Multidisciplinary Research, 3(5). https://doi.org/10.71146/kjmr351
Ahmad, N. R. (2026). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. https://doi.org/10.52152/wja5db40
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Health, Medical Research and Innovations are distributed under an open access license. Authors retain copyright and grant the journal the right of first publication. The published content can be freely accessed, shared, and reused for non-commercial purposes, provided proper citation is maintained and the original work is not altered.
